GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Ieq Capital LLC

Ieq Capital LLC decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 68.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,209 shares of the company's stock after selling 9,258 shares during the period. Ieq Capital LLC's holdings in GE HealthCare Technologies were worth $329,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. LGT Financial Advisors LLC grew its stake in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares during the period. Capital Performance Advisors LLP purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC purchased a new position in GE HealthCare Technologies in the 3rd quarter valued at approximately $31,000. Finally, Continuum Advisory LLC raised its holdings in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after purchasing an additional 168 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 1.1 %

GEHC stock traded down $0.95 during midday trading on Monday, hitting $86.40. The stock had a trading volume of 2,684,136 shares, compared to its average volume of 2,867,591. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The firm has a market cap of $39.51 billion, a PE ratio of 19.95, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company's 50-day moving average price is $86.17 and its 200 day moving average price is $86.14. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Finally, Citigroup lifted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.